He is a DM-trained specialist who treats both solid tumours and hematologic cancers, leveraging advanced systemic therapies, immunotherapy, targeted therapy, and chemotherapy. His role extends to supervising residents and participating in critical tumour board discussions, ensuring each patient receives a tailored and multidisciplinary treatment plan.

During his academic career, Dr. Shah has held significant positions at TMH, including Resident Doctor for the DM program and prior roles such as Ad-hoc Assistant Professor and MD General Medicine resident at TNMC & BYL Nair Hospital. He has contributed to research in oncology, co-authoring studies on lung cancer, glioblastoma, immunotherapy, and other malignancies, highlighting his active involvement in both academic and clinical progress.